Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

NCT00481065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Pandemic
Avian Influenza

Interventions

BIOLOGICAL: MF59-eH5N1
BIOLOGICAL: eTIV_a
BIOLOGICAL: MF59-eH5N1 + eTIV_a

Sponsor

Novartis

Collaborators

[object Object]